| Outcomes | |
| Observation time in months, median (IQR) | 10.7 (4.2–19.8) |
| AVF creation, n (%) | 196 (82.3) |
| Time to first AVF creation in days , median (IQR) | 66 (35–132.5) |
| Death, n (%) | 21 (9.2) |
| ESKD, n (%) | 178 (74.8) |
| eGFR at ESKD (mL/min/1.73 m²)a, mean (95% CI) | 8.4 (8–8.8) |
| eGFR at ESKD (mL/min/1.73 m²)a, median (IQR) | 8 (7–10) |
| ESKD modality (N = 178), n (%) | |
| Hemodialysis on AVF | 115 (64.2) |
| Hemodialysis on central venous catheter | 54 (29.7) |
| Peritoneal dialysis | 3 (1.6) |
| Kidney transplantation | 6 (3.3) |
| Reasons for starting dialysis (N = 172), n (%) | |
| Low eGFR | 105 (61) |
| Electrolytic disorders | 13 (7.6) |
| Uremia | 19 (11) |
| Fluid overload | 26 (15) |
| Acute kidney injury | 2 (1.1) |
| Post-nephrectomy | 2 (1.1) |
| Unknown | 5 (2.9) |
| Outcomes | |
| Observation time in months, median (IQR) | 10.7 (4.2–19.8) |
| AVF creation, n (%) | 196 (82.3) |
| Time to first AVF creation in days , median (IQR) | 66 (35–132.5) |
| Death, n (%) | 21 (9.2) |
| ESKD, n (%) | 178 (74.8) |
| eGFR at ESKD (mL/min/1.73 m²)a, mean (95% CI) | 8.4 (8–8.8) |
| eGFR at ESKD (mL/min/1.73 m²)a, median (IQR) | 8 (7–10) |
| ESKD modality (N = 178), n (%) | |
| Hemodialysis on AVF | 115 (64.2) |
| Hemodialysis on central venous catheter | 54 (29.7) |
| Peritoneal dialysis | 3 (1.6) |
| Kidney transplantation | 6 (3.3) |
| Reasons for starting dialysis (N = 172), n (%) | |
| Low eGFR | 105 (61) |
| Electrolytic disorders | 13 (7.6) |
| Uremia | 19 (11) |
| Fluid overload | 26 (15) |
| Acute kidney injury | 2 (1.1) |
| Post-nephrectomy | 2 (1.1) |
| Unknown | 5 (2.9) |
aMissing data = 6.
| Outcomes | |
| Observation time in months, median (IQR) | 10.7 (4.2–19.8) |
| AVF creation, n (%) | 196 (82.3) |
| Time to first AVF creation in days , median (IQR) | 66 (35–132.5) |
| Death, n (%) | 21 (9.2) |
| ESKD, n (%) | 178 (74.8) |
| eGFR at ESKD (mL/min/1.73 m²)a, mean (95% CI) | 8.4 (8–8.8) |
| eGFR at ESKD (mL/min/1.73 m²)a, median (IQR) | 8 (7–10) |
| ESKD modality (N = 178), n (%) | |
| Hemodialysis on AVF | 115 (64.2) |
| Hemodialysis on central venous catheter | 54 (29.7) |
| Peritoneal dialysis | 3 (1.6) |
| Kidney transplantation | 6 (3.3) |
| Reasons for starting dialysis (N = 172), n (%) | |
| Low eGFR | 105 (61) |
| Electrolytic disorders | 13 (7.6) |
| Uremia | 19 (11) |
| Fluid overload | 26 (15) |
| Acute kidney injury | 2 (1.1) |
| Post-nephrectomy | 2 (1.1) |
| Unknown | 5 (2.9) |
| Outcomes | |
| Observation time in months, median (IQR) | 10.7 (4.2–19.8) |
| AVF creation, n (%) | 196 (82.3) |
| Time to first AVF creation in days , median (IQR) | 66 (35–132.5) |
| Death, n (%) | 21 (9.2) |
| ESKD, n (%) | 178 (74.8) |
| eGFR at ESKD (mL/min/1.73 m²)a, mean (95% CI) | 8.4 (8–8.8) |
| eGFR at ESKD (mL/min/1.73 m²)a, median (IQR) | 8 (7–10) |
| ESKD modality (N = 178), n (%) | |
| Hemodialysis on AVF | 115 (64.2) |
| Hemodialysis on central venous catheter | 54 (29.7) |
| Peritoneal dialysis | 3 (1.6) |
| Kidney transplantation | 6 (3.3) |
| Reasons for starting dialysis (N = 172), n (%) | |
| Low eGFR | 105 (61) |
| Electrolytic disorders | 13 (7.6) |
| Uremia | 19 (11) |
| Fluid overload | 26 (15) |
| Acute kidney injury | 2 (1.1) |
| Post-nephrectomy | 2 (1.1) |
| Unknown | 5 (2.9) |
aMissing data = 6.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
